Table of Contents
ISRN Gastroenterology
Volume 2012, Article ID 207235, 10 pages
http://dx.doi.org/10.5402/2012/207235
Research Article

CCN1 Induces 𝜷 -Catenin Translocation in Esophageal Squamous Cell Carcinoma through Integrin 𝜶 11

1Laboratory of GI Injury and Cancer, VA Long Beach Healthcare System, Long Beach, CA 90822, USA
2Division of Gastroenterology, Department of Medicine, University of California, Irvine, Orange, CA 92868, USA
3Pathology and Laboratory Medicine Service, VA Long Beach Healthcare System, Long Beach, CA 90822, USA
4Diagnostic and Molecular Medicine Service, VA Long Beach Healthcare System, Long Beach, CA 90822, USA

Received 9 March 2012; Accepted 4 April 2012

Academic Editors: G.-T. Huang and F. A. Macrae

Copyright © 2012 Jianyuan Chai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Global Cancer Facts and Figures, 2nd edition, 2008.
  2. C. M. Niessen and C. J. Gottardi, “Molecular components of the adherens junction,” Biochim Biophys Acta, vol. 1778, pp. 562–571, 2008. View at Google Scholar
  3. J. Chai, C. Modak, W. Mouazzen, R. Narvaez, and J. Pham, “Epithelial or mesenchymal: where to draw the line?” BioScience Trends, vol. 4, pp. 130–142, 2010. View at Google Scholar
  4. L. F. Lau and D. Nathans, “Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells,” The EMBO Journal, vol. 4, no. 12, pp. 3145–3151, 1985. View at Google Scholar · View at Scopus
  5. D. R. Brigstock, “The CCN family: a new stimulus package,” Journal of Endocrinology, vol. 178, no. 2, pp. 169–175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Perbal, “CCN proteins: multifunctional signalling regulators,” The Lancet, vol. 363, no. 9402, pp. 62–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. A. de Melker and A. Sonnenberg, “Integrins: alternative splicing as a mechanism to regulate ligand binding and integrin signaling events,” BioEssays, vol. 21, no. 6, pp. 499–509, 1999. View at Google Scholar · View at Scopus
  8. N. Chen, C. C. Chen, and L. F. Lau, “Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin α6β1 and cell surface heparan sulfate proteoglycans,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24953–24961, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. T. Lin, C. C. Chang, B. R. Lin et al., “Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin α2β1,” Journal of Biological Chemistry, vol. 282, no. 47, pp. 34594–34604, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. V. P. Yakubenko, S. P. Yadav, and T. P. Ugarova, “Integrin αDβ2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties,” Blood, vol. 107, no. 4, pp. 1643–1650, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Schober, N. Chen, T. M. Grzeszkiewicz et al., “Identification of integrin αMβ2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions,” Blood, vol. 99, no. 12, pp. 4457–4465, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Kireeva, S. C. T. Lam, and L. F. Lau, “Adhesion of human umbilical vein endothelial cells to the immediate- early gene product Cyr61 is mediated through integrin α(v)β3,” Journal of Biological Chemistry, vol. 273, no. 5, pp. 3090–3096, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. T. M. Grzeszkiewicz, D. J. Kirschling, N. Chen, and L. F. Lau, “CYR61 stimulates human skin fibroblast migration through integrin αvβ5 and enhances mitogenesis through integrin αvβ3, independent of its carboxyl-terminal domain,” Journal of Biological Chemistry, vol. 276, no. 24, pp. 21943–21950, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Jedsadayanmata, C. C. Chen, M. L. Kireeva, L. F. Lau, and S. C. T. Lam, “Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin α(IIb)β3,” Journal of Biological Chemistry, vol. 274, no. 34, pp. 24321–24327, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. C. C. Chen, F. E. Mo, and L. F. Lau, “The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts,” Journal of Biological Chemistry, vol. 276, no. 50, pp. 47329–47337, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. T. Lin, C. C. Chang, S. T. Chen et al., “Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-κB-dependent XIAP up-regulation,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 24015–24023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Menendez, L. Vellon, I. Mehmi, P. K. Teng, D. W. Griggs, and R. Lupu, “A novel CYR61-triggered 'CYR61-αvβ3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway,” Oncogene, vol. 24, no. 5, pp. 761–779, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Xie, D. Yin, X. Tong et al., “Cyr61 Is overexpressed in gliomas and involved in integrin-linked kinase-mediated akt and β-catenin-TCF/Lef signaling pathways,” Cancer Research, vol. 64, no. 6, pp. 1987–1996, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Tong, J. O'Kelly, D. Xie et al., “Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway,” Oncogene, vol. 23, pp. 4847–4855, 2004. View at Google Scholar
  20. J. Chai, M. Norng, C. Modak, K. Reavis, W Mouazzen, and J. Pham, “CCN1 induces a reversible epithelial-mesenchymal transition in gastric epithelial cells,” Laboratory Investigation, vol. 90, pp. 1140–1151, 2010. View at Google Scholar
  21. W. Si, Q. Kang, H. H. Luu et al., “CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 2955–2964, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. C. Chen, N. Chen, and L. F. Lau, “The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts,” Journal of Biological Chemistry, vol. 276, no. 13, pp. 10443–10452, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Leu, Y. Liu, N. Chen, C. C. Chen, S. C. T. Lam, and L. F. Lau, “Identification of a novel integrin α6β1 binding site in the angiogenic inducer CCN1 (CYR61),” Journal of Biological Chemistry, vol. 278, no. 36, pp. 33801–33808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Q. Zhou, W. H. Cao, J. J. Xie et al., “Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma,” BMC Cancer, vol. 9, article 291, 2009. View at Google Scholar · View at Scopus
  25. E. Di Martino, C. P. Wild, O. Rotimi, J. S. Darnton, R. J. Olliver, and L. J. Hardie, “IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk,” Biomarkers, vol. 11, no. 6, pp. 547–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. P. Duggan, W. M. Gallagher, E. J. P. Fox, M. M. Abdel-Latif, J. V. Reynolds, and D. Kelleher, “Low pH induces co-ordinate regulation of gene expression in oesophageal cells,” Carcinogenesis, vol. 27, no. 2, pp. 319–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Modak, W. Mouazzen, R. Narvaez, K. M. Reavis, and J. Chai, “CCN1 is critical for acid-induced esophageal epithelial cell transformation,” Biochemical and Biophysical Research Communications, vol. 392, no. 4, pp. 533–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Chai, M. Norng, A. S. Tarnawski, and J. Chow, “A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats,” Gut, vol. 56, no. 5, pp. 621–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Gullberg, S. Fredriksson, M. Taussig, J. Jarvius, S. Gustafsdottir, and U. Landegren, “A sense of closeness: protein detection by proximity ligation,” Current Opinion in Biotechnology, vol. 14, pp. 82–86, 2003. View at Google Scholar
  30. O. Söderberg, M. Gullberg, M. Jarvius et al., “Direct observation of individual endogenous protein complexes in situ by proximity ligation,” Nature Methods, vol. 3, no. 12, pp. 995–1000, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Gustafsdottir, S. Wennström, S. Fredriksson et al., “Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors,” Clinical Chemistry, vol. 54, no. 7, pp. 1218–1225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. F. E. Mo, A. G. Muntean, C. C. Chen, D. B. Stolz, S. C. Watkins, and L. F. Lau, “CYR61 (CCN1) is essential for placental development and vascular integrity,” Molecular and Cellular Biology, vol. 22, no. 24, pp. 8709–8720, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. C. C. Chen and L. F. Lau, “Functions and mechanisms of action of CCN matricellular proteins,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 4, pp. 771–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. Babic, M. L. Kireeva, T. V. Kolesnikova, and L. F. Lau, “CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 11, pp. 6355–6360, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Tong, D. Xie, J. O'Kelly, C. W. Miller, C. Muller-Tidow, and H. P. Koeffler, “Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer,” Journal of Biological Chemistry, vol. 276, no. 50, pp. 47709–47714, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. S. E. Holloway, A. W. Beck, L. Girard et al., “Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer,” Journal of the American College of Surgeons, vol. 200, no. 3, pp. 371–377, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Chien, T. Kumagai, C. W. Miller et al., “Cyr61 suppresses growth of human endometrial cancer cells,” Journal of Biological Chemistry, vol. 279, no. 51, pp. 53087–53096, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. C. P. Pilarsky, U. Schmidt, C. Eissrich et al., “Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer,” Prostate, vol. 36, pp. 85–91, 1998. View at Google Scholar
  39. J. Chai, H. J. Choi, R. Narvaez, and J. Pham, “CCN1 involvement during esophageal malignancy,” The FASEB Journal, vol. 25, p. 1122.1., 2011. View at Google Scholar
  40. J. J. Xie, L. Y. Xu, Y. M. Xie et al., “Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells,” International Journal of Molecular Medicine, vol. 27, no. 3, pp. 429–434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. J. Xie, L. Y. Xu, J. Y. Wu et al., “Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells,” American Journal of Pathology, vol. 176, no. 2, pp. 939–951, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Lehnert, J. Ni, E. Leung et al., “Cloning, sequence analysis, and chromosomal localization of the novel human integrin α11 subunit (ITGA11),” Genomics, vol. 60, no. 2, pp. 179–187, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Velling, M. Kusche-Gullberg, T. Sejersen, and D. Gullberg, “cDNA cloning and chromosomal localization of human α11 integrin,” Journal of Biological Chemistry, vol. 274, no. 36, pp. 25735–25742, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. C. F. Tiger, F. Fougerousse, G. Grundström, T. Velling, and D. Gullberg, “α11β1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells,” Developmental Biology, vol. 237, no. 1, pp. 116–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. S. N. Popova, M. Barczyk, C. F. Tiger et al., “α11β1 integrin-dependent regulation of periodontal ligament function in the erupting mouse incisor,” Molecular and Cellular Biology, vol. 27, no. 12, pp. 4306–4316, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Byström, S. Carracedo, A. Behndig, D. Gullberg, and F. Pedrosa-Domellöf, “α11 integrin in the human cornea: importance in development and disease,” Investigative Ophthalmology and Visual Science, vol. 50, no. 11, pp. 5044–5053, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Y. Lin, W. Xia, J. C. Wang et al., “β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 8, pp. 4262–4266, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. F. T. Kolligs, G. Bommer, and B. Göke, “Wnt/beta-catenin/Tcf signaling: a critical pathway in gastrointestinal tumorigenesis,” Digestion, vol. 66, no. 3, pp. 131–144, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. P. K. Hsu, A. F. Y. Li, Y. C. Wang et al., “Reduced membranous β-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus,” Journal of Thoracic and Cardiovascular Surgery, vol. 135, no. 5, pp. 1029–1035, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Z. Ren, J. S. Wang, G. Q. Pan et al., “Comparative proteomic analysis of β-catenin-mediated malignant progression of esophageal squamous cell carcinoma,” Diseases of the Esophagus, vol. 23, no. 2, pp. 175–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Bailey, L. Biddlestone, N. Shepherd, H. Barr, P. Warner, and J. Jankowski, “Altered cadherin and catenin complexes in the Barrett's esophagus- dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation,” American Journal of Pathology, vol. 152, no. 1, pp. 135–144, 1998. View at Google Scholar · View at Scopus
  52. Y. S. Bian, M. C. Osterheld, F. T. Bosman, C. Fontolliet, and J. Benhattar, “Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of barrett esophagus,” American Journal of Clinical Pathology, vol. 114, no. 4, pp. 583–590, 2000. View at Publisher · View at Google Scholar · View at Scopus